1.26
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Precedente Chiudi:
$1.24
Aprire:
$1.27
Volume 24 ore:
2.64M
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.08B
Reddito:
$711.41M
Utile/perdita netta:
$-133.73M
Rapporto P/E:
-6.6316
EPS:
-0.19
Flusso di cassa netto:
$-199.99M
1 W Prestazione:
-7.35%
1M Prestazione:
-10.95%
6M Prestazione:
-21.74%
1 anno Prestazione:
-1.56%
Opko Health Inc Stock (OPK) Company Profile
Nome
Opko Health Inc
Settore
Industria
Telefono
305-575-4181
Indirizzo
4400 BISCAYNE BLVD., MIAMI, FL
Confronta OPK con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OPK
Opko Health Inc
|
1.26 | 1.08B | 711.41M | -133.73M | -199.99M | -0.19 |
![]()
TMO
Thermo Fisher Scientific Inc
|
432.59 | 159.40B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
200.83 | 141.27B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
509.53 | 38.21B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
115.55 | 30.90B | 6.53B | 1.26B | 1.31B | 4.35 |
![]()
IQV
Iqvia Holdings Inc
|
156.13 | 26.35B | 15.50B | 1.33B | 2.16B | 7.34 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-25 | Iniziato | JP Morgan | Neutral |
2023-06-29 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
2022-12-15 | Iniziato | H.C. Wainwright | Buy |
2022-01-24 | Downgrade | Barrington Research | Outperform → Mkt Perform |
2021-06-21 | Iniziato | Ladenburg Thalmann | Buy |
2019-11-25 | Iniziato | Piper Jaffray | Overweight |
2018-03-02 | Downgrade | JP Morgan | Neutral → Underweight |
2017-09-14 | Downgrade | JP Morgan | Overweight → Neutral |
2016-06-21 | Reiterato | Standpoint Research | Buy |
2016-06-03 | Iniziato | Standpoint Research | Buy |
2016-03-31 | Reiterato | Barrington Research | Outperform |
2015-10-16 | Iniziato | JP Morgan | Overweight |
2015-09-11 | Downgrade | Jefferies | Buy → Hold |
2015-03-03 | Downgrade | Oppenheimer | Outperform → Perform |
2014-05-12 | Reiterato | Oppenheimer | Outperform |
2014-03-14 | Iniziato | Oppenheimer | Outperform |
2013-11-13 | Reiterato | Ladenburg Thalmann | Buy |
2013-05-30 | Reiterato | Ladenburg Thalmann | Buy |
2012-10-22 | Iniziato | Barrington Research | Outperform |
2011-12-01 | Reiterato | Ladenburg Thalmann | Buy |
2011-07-14 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Opko Health Inc Borsa (OPK) Ultime notizie
Renaissance Technologies LLC Sells 312,950 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Voya Investment Management LLC Sells 815,679 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Purchased by Barclays PLC - MarketBeat
Q2 Earnings Forecast for OPKO Health Issued By HC Wainwright - MarketBeat
Entera Bio Announces First Quarter 2025 Financial Results and Business Updates - The Manila Times
Clinical Laboratory Tests Market Top PlayersARUP - openPR.com
Secondary Hyperparathyroidism Treatment Market Grows with Rising CKD Cases | Amgen, Sanofi, OPKO Health - openPR.com
Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - MSN
Marshall Wace LLP Has $1.36 Million Position in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Invesco Ltd. Has $2.29 Million Stake in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Piper Sandler Keeps Their Buy Rating on Opko Health (OPK) - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Q1 2025 Earnings Call Transcript - Insider Monkey
Weekly CEO Buys Highlight - GuruFocus
Labcorp Holdings Inc, BioReference Health, OPKO Health, Inc. - Olean Times Herald
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Update - MarketBeat
OPKO Health’s Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks
OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands - Yahoo Finance
Quote - OPKO Health, Inc.
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... By GuruFocus - Investing.com Canada
OPKO Health (NASDAQ:OPK) Is Carrying A Fair Bit Of Debt - simplywall.st
OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast By Investing.com - Investing.com South Africa
OPKO Health Reports Q1 2025 Financial Highlights - TipRanks
OPKO Health: Q1 Earnings Snapshot - MySA
OPKO Health Inc Q1 2025 Earnings: EPS Misses at -$0.10, Revenue Falls Short at $149.9 Million - GuruFocus
OPKO Health (OPK) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
OPKO Health (OPK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Earnings call transcript: Opko Health misses Q1 2025 earnings forecast - Investing.com
Opko Health earnings missed by $0.01, revenue fell short of estimates - Investing.com
OPKO Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - GlobeNewswire
OPKO Health Q1: $225M Oncology Asset Sale to Labcorp Plus New Oral GLP-1 Program Launch - Stock Titan
OPKO Health (NASDAQ:OPK) Now Covered by Analysts at JPMorgan Chase & Co. - MarketBeat
OPKO Health (OPK) to Release Earnings on Wednesday - MarketBeat
Pediatric Growth Hormone Deficiency Treatment Market Size - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN
Analyst Expectations For OPKO Health's Future - Benzinga
JPMorgan starts Opko Health stock with Neutral rating By Investing.com - Investing.com India
Opko Health Inc Azioni (OPK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):